Skip to content
Gyre Therapeutics, Inc. logo

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

Gyre Therapeutics, Inc.·Business Segments·3 segments·Rolls up to Income from Continuing Ops

Breakdown

Segments

Gyre PharmaceuticalsView metric
All Other SegmentsView metric